FMS
Income statement / Annual
Last year (2023), Fresenius Medical Care AG & Co. KGaA's total revenue was $19.45 B,
an increase of 0.29% from the previous year.
In 2023, Fresenius Medical Care AG & Co. KGaA's net income was $499.00 M.
See Fresenius Medical Care AG & Co. KGaA,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$19.45 B
|
$19.40 B
|
$17.62 B
|
$17.86 B
|
$17.48 B
|
$16.55 B
|
$17.78 B
|
$17.03 B
|
$15.31 B
|
$13.02 B
|
| Cost of Revenue |
$14.53 B |
$14.09 B |
$12.54 B |
$12.32 B |
$12.08 B |
$11.39 B |
$11.78 B |
$11.53 B |
$10.43 B |
$8.91 B |
| Gross Profit |
$4.93 B |
$5.31 B |
$5.08 B |
$5.54 B |
$5.40 B |
$5.16 B |
$6.00 B |
$5.50 B |
$4.88 B |
$4.11 B |
| Gross Profit Ratio |
0.25 |
0.27 |
0.29 |
0.31 |
0.31 |
0.31 |
0.34 |
0.32 |
0.32 |
0.32 |
| Research and Development
Expenses |
$231.97 M
|
$229.00 M
|
$221.00 M
|
$194.00 M
|
$168.00 M
|
$134.00 M
|
$131.00 M
|
$154.04 M
|
$128.05 M
|
$100.33 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$3.20 B
|
$3.78 B
|
$3.10 B
|
$3.17 B
|
$3.06 B
|
$2.87 B
|
$3.58 B
|
$2.90 B
|
$2.65 B
|
$2.18 B
|
| Other Expenses |
$127.26 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
-$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$3.56 B |
$4.01 B |
$3.32 B |
$3.36 B |
$3.23 B |
$3.00 B |
$3.71 B |
$3.05 B |
$2.78 B |
$2.28 B |
| Cost And Expenses |
$18.08 B |
$18.10 B |
$15.86 B |
$15.68 B |
$15.31 B |
$14.39 B |
$15.49 B |
$14.58 B |
$13.21 B |
$11.19 B |
| Interest Income |
$88.22 M |
$68.00 M |
$73.00 M |
$42.00 M |
$62.00 M |
$147.00 M |
$43.00 M |
$44.69 M |
$107.02 M |
$69.08 M |
| Interest Expense |
$424.64 M |
$360.00 M |
$353.00 M |
$410.00 M |
$491.00 M |
$448.00 M |
$397.00 M |
$430.73 M |
$464.65 M |
$407.07 M |
| Depreciation &
Amortization |
$1.75 B
|
$1.72 B
|
$1.59 B
|
$1.59 B
|
$1.55 B
|
$724.85 M
|
$735.48 M
|
$701.54 M
|
$655.81 M
|
$574.83 M
|
| EBITDA |
$3.21 B
|
$1.58 B
|
$3.55 B
|
$4.13 B
|
$3.92 B
|
$2.91 B
|
$3.00 B
|
$3.04 B
|
$2.80 B
|
$2.50 B
|
| EBITDA Ratio |
0.16 |
0.08 |
0.11 |
0.13 |
0.13 |
0.19 |
0.18 |
0.19 |
0.19 |
0.19 |
| Operating Income Ratio
|
0.07
|
-0.01
|
0.02
|
0.03
|
0.04
|
0.18
|
0.13
|
0.15
|
0.14
|
0.14
|
| Total Other
Income/Expenses Net |
-$336.42 M
|
-$292.48 M
|
-$280.43 M
|
-$368.02 M
|
-$429.44 M
|
-$301.06 M
|
-$364.82 M
|
-$363.41 M
|
-$352.83 M
|
-$337.99 M
|
| Income Before Tax |
$1.03 B |
$1.22 B |
$1.57 B |
$1.94 B |
$1.84 B |
$2.74 B |
$2.01 B |
$2.12 B |
$1.77 B |
$1.52 B |
| Income Before Tax Ratio
|
0.05
|
0.06
|
0.09
|
0.11
|
0.11
|
0.17
|
0.11
|
0.12
|
0.12
|
0.12
|
| Income Tax Expense |
$300.56 M |
$325.00 M |
$353.00 M |
$501.00 M |
$402.00 M |
$511.00 M |
$454.00 M |
$649.42 M |
$569.83 M |
$480.26 M |
| Net Income |
$499.00 M |
$673.41 M |
$969.31 M |
$1.16 B |
$1.20 B |
$1.98 B |
$1.28 B |
$1.18 B |
$941.19 M |
$859.37 M |
| Net Income Ratio |
0.03 |
0.03 |
0.06 |
0.07 |
0.07 |
0.12 |
0.07 |
0.07 |
0.06 |
0.07 |
| EPS |
1.7 |
2.3 |
3.31 |
3.96 |
3.96 |
3.23 |
2.09 |
1.87 |
1.57 |
1.42 |
| EPS Diluted |
1.7 |
2.3 |
3.31 |
3.96 |
3.96 |
3.23 |
2.08 |
1.87 |
1.57 |
1.42 |
| Weighted Average Shares
Out |
$293.41 M
|
$293.25 M
|
$292.94 M
|
$294.06 M
|
$302.69 M
|
$613.08 M
|
$613.13 M
|
$611.50 M
|
$608.88 M
|
$604.68 M
|
| Weighted Average Shares
Out Diluted |
$293.41 M
|
$293.25 M
|
$293.07 M
|
$294.28 M
|
$302.75 M
|
$614.55 M
|
$615.28 M
|
$613.39 M
|
$610.19 M
|
$605.95 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
